TMEM191B (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:728229, HGNC:33600, NM_001242313, NP_001229242, TMEM191B, XM_011546160, XM_024452265, XP_011544462, XP_024308033, XR_951236, transmembrane protein 191B

Id:ENSG00000278558

Hgnc:HGNC:33600

Entrez:728229

Ensembl:ENSG00000278558

Description:transmembrane protein 191B

Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TMEM191B's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TMEM191B.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TMEM191B.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TMEM191B.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TMEM191B.

Results found

Linked to

	Label	Description
	GSE216043 7 V 9 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE187006 3 V 2 VALPROIC ACID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE146358 dopamine 5 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE236228 penfluridol 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE146358 dopamine 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE160001,GSE160670 3 V 2 LAPATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE210682 0 V 3 METHADONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE236228 0 V 1 PENFLURIDOL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE232944 APC CTNNB1 overexpression HT29 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE235066 carboplatin 7 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE216043 7 V 9 CISPLATIN HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE187006 3 V 2 VALPROIC ACID HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE146358 dopamine 5 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE236228 penfluridol 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE146358 dopamine 5 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE160001,GSE160670 3 V 2 LAPATINIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE210682 0 V 3 METHADONE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE236228 0 V 1 PENFLURIDOL HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE232944 APC CTNNB1 overexpression HT29 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE235066 carboplatin 7 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.